NEW YORK, Aug 16 – Orchid BioSciences said Thursday it had received approval to provide its cystic fibrosis genetic screening test to certain approved labs in the United States.

The Elucigene CF 29 test screens for 29 common mutations associated with cystic fibrosis and includes the 25 mutations the American College of Medical Genetics recommends for cystic fibrosis testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.